E-ISSN:
1308-5263
Archive
Most Accessed Articles
Most Accessed Articles
Most Cited Articles
Aims and Scope
Instructions For Authors
Editorial Board
Advisory Board
Manuscript Submission
Manuscript Submission
Why to Submit
Search
Contact
Hematological Malignancy Patients, COVID-19, and Favipiravir [Turk J Hematol]
Turk J Hematol. 2021; 38(4):
331-332 | DOI:
10.4274/tjh.galenos.2021.2021.0582
Hematological Malignancy Patients, COVID-19, and Favipiravir
Rujittika Mungmunpuntipantip
1
,
Viroj Wiwanitkit
2
1
Private Academic Consultant, Bangkok, Thailand
2
D.Y. Patil University, Pune, India
Keywords:
Malignancy, COVID-19, Favipiravir
Hematolojik Malignite Hastaları, COVID-19 ve Favipiravir
Rujittika Mungmunpuntipantip
1
,
Viroj Wiwanitkit
2
1
Private Academic Consultant, Bangkok, Thailand
2
D.Y. Patil University, Pune, India
Anahtar Kelimeler:
COVID-19, Favipiravir
Rujittika Mungmunpuntipantip
, Viroj Wiwanitkit. Hematological Malignancy Patients, COVID-19, and Favipiravir. Turk J Hematol. 2021; 38(4): 331-332
Corresponding Author:
Rujittika Mungmunpuntipantip, Thailand
TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author
Similar articles
PubMed
Google Scholar
In authors and institutes
In titles and abstracts
In keywords
In all
PubMed
Protein
Nucleotide
Structure
Genome
PMC
OMIM
Taxonomy
Books
PopSet
GEO
GEO DataSets
UniSTS
Domains
SNP
Journals
UniGene
NCBI Web Site
MeSH